Day: February 13, 2024

Cutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces and position themselves at the forefront of the global liquid biopsy marketplace

Written by Customer Service on February 13, 2024. Posted in Mergers And Acquisitions.

A Binding LOI has been executed: GEDiCube will acquire 75% of Cyclomics at Closing. Expected breakthroughs by combining technologies in (early) cancer detection and recurrence of cancer with a single vial of blood. Cyclomics’ 4th generation liquid biopsy genomics platform is a truly “Omni-Omic” blood test ready for AI application GEDiCube’s award-winning AI is developing high-performance biomarker panels for 13 different cancers. GEDiCube’s partnership with NVIDIA’s Inception program will help expand to multi-modal capabilities by adding imaging.The combined Companies aim to Disrupt Cancer Diagnosis and treatment through early disease and recurrence detection, prediction of response to treatment, and personalized therapy. LOS ANGELES, Feb. 13, 2024 (GLOBE NEWSWIRE) — GEDi Cube Intl Ltd., a London and Netherlands-based advanced...

Mullen Reports Strongest Fiscal Quarter in Company’s History for Three Months Ended Dec. 31, 2023

Written by Customer Service on February 13, 2024. Posted in Earnings Releases And Operating Results.

Company reports financial results and current business update Stockholders’ equity $271,814,097.00 as of December 31, 2023 BREA, Calif., Feb. 13, 2024 (GLOBE NEWSWIRE) — via IBN — Mullen Automotive Inc. (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announces financial results for the three months ended Dec. 31, 2023, and a business update. Commenting on the results for the three months ended Dec. 31, 2023, and recent Company developments, CEO and chairman David Michery stated, “We are coming off our strongest quarter to date for vehicle production and deliveries. For the three months ended Dec. 31, 2023, the Company delivered 231 vehicles. For the 12 months ended Sept. 30, 2023, the Company delivered a total of 35 vehicles. Our pivot to focus on commercial EVs last year was a strategic move and has...

AI Pioneer GEDi Cube and Biotech Innovator Renovaro Biosciences Combine Forces to Accelerate Personalized Medicine

Written by Customer Service on February 13, 2024. Posted in Mergers And Acquisitions.

LOS ANGELES, Feb. 13, 2024 (GLOBE NEWSWIRE) — Renovaro Inc. (NASDAQ: RENB) announced today that it completed its acquisition of GEDi Cube Intl Ltd. (“GEDiCube”). Renovaro, which means renew, combines the power of the AI Health Tech platform of GEDiCube with the advanced cell and gene-therapy Biotech platform of Renovaro Biosciences to accelerate precision, personalized medicine, and a new era in healthcare innovation. The two subsidiaries will be under the parent organization, which was renamed Renovaro Inc. The combination will see Renovaro’s existing CEO, The Hon. Mark Dybul, MD, leading Renovaro Inc., with GEDiCube’s CEO, Coen van Kalken, MD PhD, becoming the Managing Director and President of GEDiCube and Dr. Francois Binette, currently, Executive Vice-President and COO of Renovaro, becoming the Managing Director and President...

Silynxcom Received $550,000 in Orders from Israel Defense Forces and Israeli Police Forces Since Beginning of Year

Written by Customer Service on February 13, 2024. Posted in Public Companies.

Repeat Orders from the Israel Defense Forces and Israeli police forces since October 2023 accumulates to over $4.85 million Netanya, Israel, Feb. 13, 2024 (GLOBE NEWSWIRE) — Silynxcom Ltd. (NYSE American: SYNX) (“Silynxcom” or the “Company”), a manufacturer and developer of ruggedized tactical communication headset devices, today announced that it has received repeat purchase orders of approximately $550,000 since the beginning of 2024 from the Israel Defense Forces and Israeli police forces, for its advanced military headset system family of products. Since October 2023, the Company has received over $4.85 million in orders from the Israel Defense Forces and Israeli police forces. “Repeat orders serve as a strong indicator and confirmation of the distinct capabilities and effective deployment of our innovative in-ear headset...

E-Cite to Include Gas Powered Options for Both Its GT and C3 Sports Cars Along with Current Electric Versions

Written by Customer Service on February 13, 2024. Posted in Public Companies.

E-Cite Motors Goes ICE ICE Baby! BOTHELL, WA, Feb. 13, 2024 (GLOBE NEWSWIRE) — via NewMediaWire – VaporBrands International, Inc. dba E-Cite Motors Group, (OTC:VAPR) reveals that it will offer gas powered versions of its “GT” and “C3” mid-engine sports car models previously only to be available as all electric. Both models will be available with gasoline internal combustion engines (ICE) and current electric (EV) options. The petrol-powered version of the GT will bear the designation of “IC-GT” and the electric version the “EV-GT”, whereas the C3 model “IC-C3” and “EV-C3” respectively. E-Cite’s GT model has been formally approved by the National Highway Traffic Safety Administration “NHTSA” in accordance with (49 CFR Part 586) to be “new vehicles” legally driven on public roads in the US and the C3’s submission is currently under...

AI-Media’s LEXI Tool Kit Expanded with LEXI Recorded – Breakthrough Solution for the Growing VOD Market

Written by Customer Service on February 13, 2024. Posted in Public Companies.

AI-Media Launches LEXI RecordedLEXI Recorded offers fast turnaround, is cost competitive, has excellent accuracy and integration options for captioning recorded content.BROOKLYN, N.Y., Feb. 13, 2024 (GLOBE NEWSWIRE) — AI-Media is excited to announce the launch of its VOD automated captioning solution, LEXI Recorded. This groundbreaking product, created initially for a major sporting franchise, utilizes the cutting-edge AI (Artificial Intelligence) technology of their flagship LEXI product. LEXI Recorded will address the ever-increasing demand for high volume, fast turnaround and easy captioning of recorded content, while ensuring high accuracy and cost-effectiveness. It is also capable of seamlessly integrating with a customer’s media management system, to become an end-to-end media production workflow, and delivering...

Adial Pharmaceuticals Awarded New Patent Notice of Allowance from the United States Patent and Trademark Office

Written by Customer Service on February 13, 2024. Posted in Public Companies.

Expands patent estate covering Adial’s unique molecular genetic approach to diagnosing and potentially treating alcohol and drug dependence CHARLOTTESVILLE, Va., Feb. 13, 2024 (GLOBE NEWSWIRE) — Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today announced it has been awarded an important patent which expands the estate covering the combination of the Company’s proprietary genetic diagnostic to identify patients with specific genotypes for genetically targeted treatment of alcohol use disorder (AUD) and drug dependencies, such as opioid use disorder (OUD), with the Company’s lead investigational new drug product AD04. “Following a post hoc analysis of our...

AGS to Report Fourth Quarter and Full Year 2023 Results on Tuesday, March 5, 2024

Written by Customer Service on February 13, 2024. Posted in Public Companies.

LAS VEGAS, Feb. 13, 2024 (GLOBE NEWSWIRE) — PlayAGS, Incorporated (NYSE: AGS) (“AGS” or the “Company”) today announced it will release its financial results for the fourth quarter and fiscal year ended December 31, 2023, after the market close on Tuesday, March 5, 2024. The Company will host an investor conference call and live webcast the same day at 5 p.m. EST to further discuss its fourth quarter and full year financial performance. The Company encourages participants to pre-register for the conference call by using the following link: AGS Q4 and Full Year 2023 Earnings Call. Callers who pre-register will be given a conference passcode and unique PIN to gain immediate access to the call and bypass the live operator. Participants may pre-register at any time, including up to the call start time. To pre-register,...

Kartoon Channel! Achieves Record Revenue, Subscriber Growth, and Global Coverage

Written by Customer Service on February 13, 2024. Posted in Public Companies.

Top ranked content destinationTop ranked content destinationKartoon Channel Worldwide!Kartoon Channel Worldwide!Kartoon Channel! U.S. Paid Subscribers Increased in 2023, with New Trials More Than Doubling in Q4 Kartoon Channel! International Market Penetration Increases with Dedicated Channels in 61 Territories and Branded Blocks Across Europe, Middle East, Africa, and Latin America, Reaching a Combined Population of Nearly 1.8 Billion Kartoon Channel!’s Apple App Store User Rating Beats All Major Competitors, Including Netflix, Disney+, Cartoon Network, and Nickelodeon BEVERLY HILLS, Calif., Feb. 13, 2024 (GLOBE NEWSWIRE) — Kartoon Studios, Inc. (NYSE American: TOON) today announced its streaming service business, which premiered in June 2020, has achieved record revenue, increased its paid subscribers, expanded...

IR-MED to Report New Clinical Efficacy Data for Detection of Pressure Injuries with its AI- Based PressureSafe™ Device at NPIAP 2024 Annual Conference on February 16

Written by Customer Service on February 13, 2024. Posted in Public Companies.

IR-Med, Inc.New Clinical Efficacy Data for Detection of Pressure Injuries with its AI- Based PressureSafe™ DeviceFinal results to be reported from a study conducted at two medical centers owned by Clalit, the world’s second largest health maintenance organization (HMO) and the largest in Israel PressureSafe, for the detection of pressure injuries, addresses a healthcare challenge that costs $26.8 billion and causes 60,000 deaths annually in the U.S. aloneRosh Pina, Israel, Feb. 13, 2024 (GLOBE NEWSWIRE) — IR-MED Inc., (“IR-MED” or the “Company”) (OTCQB:IRME), developer of a noninvasive artificial intelligence (AI) driven spectrographic analysis technology platform to address significant healthcare needs, announced today that final data from a study conducted at two medical centers, Beit Rivka Hospital, and...

M	T	W	T	F	S	S
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29

Day: February 13, 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals